Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1311 | 2725 | 27.7 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
431 | 3 | OBSTRUCTIVE SLEEP APNEA//SLEEP APNEA//RESTLESS LEGS SYNDROME | 27358 |
2035 | 2 | ANTIEMETICS//EMESIS//VOMITING | 5392 |
1311 | 1 | ANTIEMETICS//CHEMOTHERAPY INDUCED NAUSEA AND VOMITING//GRANISETRON | 2725 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTIEMETICS | authKW | 2259969 | 15% | 50% | 403 |
2 | CHEMOTHERAPY INDUCED NAUSEA AND VOMITING | authKW | 1669021 | 6% | 93% | 161 |
3 | GRANISETRON | authKW | 1302279 | 7% | 58% | 202 |
4 | PALONOSETRON | authKW | 1276292 | 5% | 80% | 142 |
5 | NAUSEA | authKW | 1225940 | 14% | 29% | 382 |
6 | APREPITANT | authKW | 1146167 | 6% | 65% | 158 |
7 | ONDANSETRON | authKW | 864023 | 10% | 29% | 267 |
8 | EMESIS | authKW | 818156 | 8% | 32% | 225 |
9 | VOMITING | authKW | 797343 | 12% | 22% | 319 |
10 | CINV | authKW | 642138 | 2% | 87% | 66 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 36206 | 59% | 0% | 1610 |
2 | Health Care Sciences & Services | 12281 | 15% | 0% | 400 |
3 | Rehabilitation | 8363 | 12% | 0% | 322 |
4 | Pharmacology & Pharmacy | 3105 | 22% | 0% | 586 |
5 | Medicine, General & Internal | 972 | 10% | 0% | 279 |
6 | Nursing | 432 | 3% | 0% | 71 |
7 | Hematology | 231 | 4% | 0% | 99 |
8 | Psychology, Clinical | 101 | 2% | 0% | 50 |
9 | Pediatrics | 74 | 3% | 0% | 78 |
10 | Transplantation | 40 | 1% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COMPASS ONCOL | 57618 | 0% | 86% | 6 |
2 | UNIT CELL THER Y TRANSPLANTAT | 33611 | 0% | 100% | 3 |
3 | INTERNAL MED ONCOL SCI | 22865 | 0% | 29% | 7 |
4 | BUSINESS UNIT ONCOL CANC SUPPORT CARE | 22408 | 0% | 100% | 2 |
5 | CORP CLIN DEV STAT DATA MANAGEMENT | 22408 | 0% | 100% | 2 |
6 | ONCOHAEMATOL BMT UNIT | 22408 | 0% | 100% | 2 |
7 | REG HAEMATOL ONCOL | 22408 | 0% | 100% | 2 |
8 | US CLIN PHARMACOKINET | 22408 | 0% | 100% | 2 |
9 | BEHAV MED UNIT | 17489 | 0% | 16% | 10 |
10 | EASTERN EUROPE | 16803 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SUPPORTIVE CARE IN CANCER | 248687 | 11% | 7% | 308 |
2 | ONCOLOGY | 13871 | 3% | 2% | 70 |
3 | EUROPEAN JOURNAL OF CANCER | 7819 | 3% | 1% | 84 |
4 | ANNALS OF ONCOLOGY | 7559 | 3% | 1% | 75 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 6922 | 4% | 1% | 101 |
6 | CANCER MANAGEMENT AND RESEARCH | 5827 | 0% | 7% | 7 |
7 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 5811 | 2% | 1% | 46 |
8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 5776 | 2% | 1% | 62 |
9 | ANTI-CANCER DRUGS | 4639 | 1% | 1% | 37 |
10 | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 4523 | 1% | 1% | 37 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIEMETICS | 2259969 | 15% | 50% | 403 | Search ANTIEMETICS | Search ANTIEMETICS |
2 | CHEMOTHERAPY INDUCED NAUSEA AND VOMITING | 1669021 | 6% | 93% | 161 | Search CHEMOTHERAPY+INDUCED+NAUSEA+AND+VOMITING | Search CHEMOTHERAPY+INDUCED+NAUSEA+AND+VOMITING |
3 | GRANISETRON | 1302279 | 7% | 58% | 202 | Search GRANISETRON | Search GRANISETRON |
4 | PALONOSETRON | 1276292 | 5% | 80% | 142 | Search PALONOSETRON | Search PALONOSETRON |
5 | NAUSEA | 1225940 | 14% | 29% | 382 | Search NAUSEA | Search NAUSEA |
6 | APREPITANT | 1146167 | 6% | 65% | 158 | Search APREPITANT | Search APREPITANT |
7 | ONDANSETRON | 864023 | 10% | 29% | 267 | Search ONDANSETRON | Search ONDANSETRON |
8 | EMESIS | 818156 | 8% | 32% | 225 | Search EMESIS | Search EMESIS |
9 | VOMITING | 797343 | 12% | 22% | 319 | Search VOMITING | Search VOMITING |
10 | CINV | 642138 | 2% | 87% | 66 | Search CINV | Search CINV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GRALLA, RJ , OSOBA, D , KRIS, MG , KIRKBRIDE, P , HESKETH, PJ , CHINNERY, LW , CLARK-SNOW, R , GILL, DP , GROSHEN, S , GRUNBERG, S , ET AL (1999) RECOMMENDATIONS FOR THE USE OF ANTIEMETICS: EVIDENCE-BASED, CLINICAL PRACTICE GUIDELINES.JOURNAL OF CLINICAL ONCOLOGY. VOL. 17. ISSUE 9. P. 2971 -2994 | 200 | 96% | 340 |
2 | ROCK, EM , LIMEBEER, CL , PARKER, LA , (2014) ANTICIPATORY NAUSEA IN ANIMAL MODELS: A REVIEW OF POTENTIAL NOVEL THERAPEUTIC TREATMENTS.EXPERIMENTAL BRAIN RESEARCH. VOL. 232. ISSUE 8. P. 2511 -2534 | 187 | 77% | 3 |
3 | DU BOIS, A , (1998) MANAGEMENT OF CHEMOTHERAPY-INDUCED EMESIS: WHAT IS THE STANDARD AFTER 20 YEARS OF CLINICAL RESEARCH?.MEDIZINISCHE KLINIK. VOL. 93. ISSUE . P. 3 -17 | 230 | 85% | 5 |
4 | ETTINGER, DS , ARMSTRONG, DK , BARBOUR, S , BERGER, MJ , BIERMAN, PJ , BRADBURY, B , ELLIS, G , KIRKEGAARD, S , KLOTH, DD , KRIS, MG , ET AL (2012) ANTIEMESIS CLINICAL PRACTICE GUIDELINES IN ONCOLOGY.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 10. ISSUE 4. P. 456 -485 | 115 | 95% | 32 |
5 | KRIS, MG , HESKETH, PJ , SOMERFIELD, MR , FEYER, P , CLARK-SNOW, R , KOELLER, JM , MORROW, GR , CHINNERY, LW , CHESNEY, MJ , GRALLA, RJ , ET AL (2006) AMERICAN SOCIETY OF CLINICAL ONCOLOGY GUIDELINE FOR ANTIEMETICS IN ONCOLOGY: UPDATE 2006.JOURNAL OF CLINICAL ONCOLOGY. VOL. 24. ISSUE 18. P. 2932-2947 | 87 | 100% | 320 |
6 | NAVARI, RM , AAPRO, M , (2016) ANTIEMETIC PROPHYLAXIS FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 374. ISSUE 14. P. 1356 -1367 | 55 | 96% | 15 |
7 | ETTINGER, DS , ARMSTRONG, DK , BARBOUR, S , BERGER, MJ , BIERMAN, PJ , BRADBURY, B , ELLIS, G , KIRKEGAARD, S , KLOTH, DD , KRIS, MG , ET AL (2009) ANTIEMESIS CLINICAL PRACTICE GUIDELINES IN ONCOLOGY.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 7. ISSUE 5. P. 572-595 | 84 | 99% | 12 |
8 | ROILA, F , MOLASSIOTIS, A , HERRSTEDT, J , AAPRO, M , GRALLA, RJ , BRUERA, E , CLARK-SNOW, RA , DUPUIS, LL , EINHORN, LH , FEYER, P , ET AL (2016) 2016 MASCC AND ESMO GUIDELINE UPDATE FOR THE PREVENTION OF CHEMOTHERAPY- AND RADIOTHERAPY-INDUCED NAUSEA AND VOMITING AND OF NAUSEA AND VOMITING IN ADVANCED CANCER PATIENTS.ANNALS OF ONCOLOGY. VOL. 27. ISSUE . P. V119 -V133 | 57 | 93% | 4 |
9 | SMITH, LA , AZARIAH, F , LAVENDER, VTC , STONER, NS , BETTIOL, S , (2015) CANNABINOIDS FOR NAUSEA AND VOMITING IN ADULTS WITH CANCER RECEIVING CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 83 | 81% | 2 |
10 | SOMMARIVA, S , PONGIGLIONE, B , TARRICONE, R , (2016) IMPACT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY OF LIFE AND RESOURCE UTILIZATION: A SYSTEMATIC REVIEW.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 99. ISSUE . P. 13 -36 | 63 | 91% | 2 |
Classes with closest relation at Level 1 |